Skip to main content
. Author manuscript; available in PMC: 2013 Sep 7.
Published in final edited form as: Oncogene. 2012 Apr 30;32(10):1305–1315. doi: 10.1038/onc.2012.140

Fig 5d. Effects of Rosiglitazone treatment on formation of single lumen glands in Caco-2 clones.

Fig 5d

Neither Rosiglitazone nor GW9662 treatment affected lumen formation in caco-2 glands. In Caco-2 ShPTEN glands, treatment by Rosiglitazone (Rosi) enhanced single lumen formation although these effects were ameliorated by GW treatment (control vs Rosi vs Rosi +GW = 35 ± 3.7 vs 61 ± 3.7 vs 39.0 ± 1.8). Effects of cell type and drug treatment on single lumen formation were significant (p<0.001; Two way ANOVA).